TURTLE CAMERON (Chief Executive Officer) sold 2.5% of their position (15K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.32M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 7/3/2026ACC: 0001636282-26-000086
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-15K
Net shares
Net seller
$1.32M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
15K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−10.18K
Price / share
$87.44
Trade value
$889.79K
% of position
1.7%
7/1/2026
597.54K→587.36K
Common Stock
Direct
Shares
−4.23K
Price / share
$88.12
Trade value
$373.10K
% of position
0.7%
7/1/2026
587.36K→583.13K
Common Stock
Direct
Shares
−590.00
Price / share
$88.91
Trade value
$52.46K
% of position
0.1%
7/1/2026
583.13K→582.54K
Total
Net shares
−15K
Net value
-$1.32M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | S · Sale | −10.18K | $87.44 | $889.79K | 1.7% | 597.54K | 587.36K |
| Common Stock Direct | 7/1/2026 | S · Sale | −4.23K | $88.12 | $373.10K | 0.7% | 587.36K | 583.13K |
| Common Stock Direct | 7/1/2026 | S · Sale | −590.00 | $88.91 | $52.46K | 0.1% | 583.13K | 582.54K |
| Total | −15K | -$1.32M | ||||||
Derivative Transactions0
No derivative transactions reported